All regulatory updates
1373 results found
EU proposes TBPH for Stockholm Convention Annex A/B listing
The European Commission has proposed a Council Decision authorizing the EU to submit a proposal for listing bis(2-ethylhexyl) tetrabromophthalate (TBPH) in Annex A or Annex B to the Stockholm Convention. TBPH is a brominated flame retardant used in plastics, electronics, construction materials, and wire insulation. If the Council adopts this decision, the EU will formally submit the TBPH nomination to the Stockholm Convention, initiating the POPRC review process for potential global restriction under the Convention.
ECHA adds n-hexane and bisphenol AF (and its salts) to the REACH SVHC Candidate List (total 253 entries)
ECHA updated the REACH Candidate List (SVHC) by adding two new entries: (1) n-hexane (EC 203-777-6; CAS 110-54-3) identified under Article 57(f) (human health; STOT RE), and (2) 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and its salts (bisphenol AF and its salts) identified under Article 57(c) (toxic for reproduction). The Candidate List total increased to 253 entries. This update triggers standard REACH Candidate List compliance actions, including Article 33 communication for articles containing listed SVHCs >0.1% w/w, potential Article 7(2) notifications for article producers/importers where conditions are met, and SDS updates for substances/mixtures supplied in the EU/EEA.
EU Proposes TBPH for Stockholm Convention Listing
The European Commission has adopted a proposal for a Council Decision to submit, on behalf of the European Union, a proposal for listing TBPH (tetrabromobisphenol-A related compound) in Annex A or B to the Stockholm Convention. The scientific dossier will be reviewed at the POPRC meeting in October 2026, with a submission deadline of April 2026. This initiates the formal process under Article 8 of the Convention for considering new persistent organic pollutants for global restriction.
ECHA adds n-hexane and BPAF to SVHC Candidate List
ECHA added two new substances to the REACH SVHC Candidate List: n-hexane (EC 203-777-6, CAS 110-54-3) identified for specific target organ toxicity after repeated exposure - marking the first SVHC identified solely on neurotoxicity grounds under Article 57(f) equivalent level of concern; and 4,4'-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol (BPAF) and its salts identified for reproductive toxicity under Article 57(c). The Candidate List now contains 253 entries. Companies have until August 4, 2026 (6 months) to submit SCIP notifications for articles containing these substances above 0.1% w/w if quantities exceed 1 tonne per year. Article 33 communication obligations apply immediately.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation to include certain SVHC Candidate List substances in REACH Annex XIV (Authorisation List). This is an upstream step toward potential Annex XIV inclusion (which would later impose authorisation requirements and set latest application and sunset dates via subsequent Commission action). Compliance teams should review whether any recommended substances are used in products/processes and consider submitting comments and preparing for potential authorisation planning and supply-chain communication.
ECHA publishes Draft 13th Recommendation documents for potential inclusion of priority SVHCs in REACH Annex XIV (Authorisation List)
ECHA published supporting documents for its Draft 13th Recommendation of priority substances for potential inclusion in REACH Annex XIV (Authorisation List), including draft Annex XIV entry structures and background/prioritisation documents. This is a draft/pipeline step (not yet a binding Annex XIV amendment), but it signals which SVHCs may be advanced toward authorisation requirements, informing early substitution planning and monitoring of latest application date/sunset date proposals once finalized by the European Commission.
ECHA opens consultation on draft recommendation to include four Candidate List substances in the REACH Authorisation List (Annex XIV)
ECHA launched a public consultation on its draft recommendation to the European Commission to add four Candidate List substances to the REACH Authorisation List (Annex XIV). Compliance teams should monitor this pipeline step because Annex XIV inclusion can introduce authorisation obligations for continued use/placing on the market (subject to future sunset dates set in any eventual Annex XIV entries). The consultation is open for stakeholder input until 2 May 2026.
ECHA opened public consultation on the Draft 13th Recommendation to include four SVHCs in the REACH Authorisation List (Annex XIV)
ECHA published the Draft 13th Recommendation and opened a public consultation (2 Feb 2026 to 2 May 2026) on prioritising four SVHCs for potential inclusion in the REACH Authorisation List (Annex XIV): bumetrizole (UV-326), UV-329, triphenyl phosphate, and 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one. This consultation is a key step in the SVHC-to-authorisation pathway; affected companies should assess uses and consider submitting evidence on uses, alternatives, and socio-economic impacts.
ECHA opens public consultation on draft recommendation to include four Candidate List substances in REACH Authorisation List (Annex XIV)
ECHA opened a public consultation on its draft recommendation to the European Commission to include four SVHC Candidate List substances in REACH Annex XIV (Authorisation List). Stakeholders are invited to submit information (e.g., uses, volumes, potential exemptions, and supply chain impacts) to inform ECHA’s final recommendation. This is a proposed/pipeline step (not yet a legal Annex XIV amendment) but is highly relevant for companies using these substances, as Annex XIV listing can lead to authorisation obligations and potential phase-out/substitution planning.
ECHA opens public consultation on draft recommendation to include four Candidate List substances in REACH Authorisation List (Annex XIV)
ECHA opened a public consultation on its draft recommendation to the European Commission to include four SVHC Candidate List substances in REACH Annex XIV (Authorisation List). Stakeholders are invited to submit information (e.g., uses, volumes, potential exemptions, and supply chain impacts) to inform ECHA’s final recommendation. This is a proposed/pipeline step (not yet a legal Annex XIV amendment) but is highly relevant for companies using these substances, as Annex XIV listing can lead to authorisation obligations and potential phase-out/substitution planning.
ECHA opened public consultation on the draft 13th recommendation for inclusion of Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA published the draft 13th recommendation for inclusion of Candidate List substances of very high concern (SVHCs) in REACH Annex XIV (Authorisation List) and opened a public consultation. This is a key downstream step in the SVHC pathway because Annex XIV listing can ultimately require companies to obtain authorisation for continued use/placing on the market of listed substances after specified sunset dates (once Annex XIV is formally amended via EU legislation). Compliance teams should review whether any substances relevant to their portfolios are covered and consider preparing comments and internal substitution/authorisation strategies.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation to include certain SVHC Candidate List substances in REACH Annex XIV (Authorisation List). This is an upstream step toward potential Annex XIV inclusion (which would later impose authorisation requirements and set latest application and sunset dates via subsequent Commission action). Compliance teams should review whether any recommended substances are used in products/processes and consider submitting comments and preparing for potential authorisation planning and supply-chain communication.
ECHA opens public consultation on draft 13th recommendation for inclusion of SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for prioritising certain Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation period runs from 2 February 2026 to 2 May 2026. This is a key SVHC-to-authorisation pipeline milestone: affected manufacturers/importers/downstream users should review whether any of the recommended substances are in their supply chains and consider submitting comments, as future Annex XIV inclusion can lead to authorisation obligations and phase-out pressures.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for inclusion of certain Candidate List SVHCs in REACH Annex XIV (Authorisation List). This is a key SVHC-related downstream step: substances recommended for Annex XIV can later be added by the European Commission via amendment, triggering authorisation requirements (including latest application and sunset dates) for continued use. Consultation window shown is 02 Feb 2026 to 02 May 2026, with linked draft recommendation and supporting documents.
ECHA opened public consultation on the Draft 13th Recommendation to include four SVHCs in the REACH Authorisation List (Annex XIV)
ECHA published the Draft 13th Recommendation and opened a public consultation (2 Feb 2026 to 2 May 2026) on prioritising four SVHCs for potential inclusion in the REACH Authorisation List (Annex XIV): bumetrizole (UV-326), UV-329, triphenyl phosphate, and 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one. This consultation is a key step in the SVHC-to-authorisation pathway; affected companies should assess uses and consider submitting evidence on uses, alternatives, and socio-economic impacts.
ECHA opens public consultation on draft 13th recommendation for inclusion of SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for prioritising certain Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation period runs from 2 February 2026 to 2 May 2026. This is a key SVHC-to-authorisation pipeline milestone: affected manufacturers/importers/downstream users should review whether any of the recommended substances are in their supply chains and consider submitting comments, as future Annex XIV inclusion can lead to authorisation obligations and phase-out pressures.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for inclusion of certain Candidate List SVHCs in REACH Annex XIV (Authorisation List). This is a key SVHC-related downstream step: substances recommended for Annex XIV can later be added by the European Commission via amendment, triggering authorisation requirements (including latest application and sunset dates) for continued use. Consultation window shown is 02 Feb 2026 to 02 May 2026, with linked draft recommendation and supporting documents.
ECHA opens public consultation on the draft 13th recommendation for inclusion of Candidate List SVHCs in REACH Annex XIV (Authorisation List) (02 Feb 2026–02 May 2026)
ECHA has opened a public consultation on its draft 13th recommendation of priority SVHCs from the Candidate List for possible inclusion in REACH Annex XIV (Authorisation List). The consultation window shown is 02 February 2026 through 02 May 2026. This is a key step in the SVHC-to-authorisation pipeline; if substances are later added to Annex XIV by the European Commission, authorisation requirements could apply for non-exempt uses after future latest application/sunset dates. Compliance teams should evaluate business impacts, substitution plans, and consider submitting comments/evidence during the consultation period.
ECHA opens public consultation on the draft 13th recommendation for inclusion of Candidate List SVHCs in REACH Annex XIV (Authorisation List) (02 Feb 2026–02 May 2026)
ECHA has opened a public consultation on its draft 13th recommendation of priority SVHCs from the Candidate List for possible inclusion in REACH Annex XIV (Authorisation List). The consultation window shown is 02 February 2026 through 02 May 2026. This is a key step in the SVHC-to-authorisation pipeline; if substances are later added to Annex XIV by the European Commission, authorisation requirements could apply for non-exempt uses after future latest application/sunset dates. Compliance teams should evaluate business impacts, substitution plans, and consider submitting comments/evidence during the consultation period.
ECHA opens consultation on draft recommendation to include four Candidate List substances in the REACH Authorisation List (Annex XIV)
ECHA launched a public consultation on its draft recommendation to the European Commission to add four Candidate List substances to the REACH Authorisation List (Annex XIV). Compliance teams should monitor this pipeline step because Annex XIV inclusion can introduce authorisation obligations for continued use/placing on the market (subject to future sunset dates set in any eventual Annex XIV entries). The consultation is open for stakeholder input until 2 May 2026.